95 related articles for article (PubMed ID: 10052912)
1. The production of a novel carbapenem-hydrolysing beta-lactamase in Aeromonas veronii biovar sobria, and its association with imipenem resistance.
Stunt RA; Amyes AK; Thomson CJ; Payne DJ; Amyes SG
J Antimicrob Chemother; 1998 Dec; 42(6):835-6. PubMed ID: 10052912
[No Abstract] [Full Text] [Related]
2. Beta-lactamases with high activity against imipenem and Sch 34343 from Aeromonas hydrophila.
Shannon K; King A; Phillips I
J Antimicrob Chemother; 1986 Jan; 17(1):45-50. PubMed ID: 3485091
[TBL] [Abstract][Full Text] [Related]
3. Carbapenem-hydrolysing beta-lactamase from clinical isolates of Pseudomonas aeruginosa in Portugal.
Cardoso O; Sousa JC; Leitão R; Peixe L
J Antimicrob Chemother; 1999 Jul; 44(1):135. PubMed ID: 10459824
[No Abstract] [Full Text] [Related]
4. Sensitivity pattern and beta-lactamase production in clinical isolates of Aeromonas strains.
Ahmed A; Hafiz S; Ahmed QT; Majeed H; Syed S
J Pak Med Assoc; 1998 Jun; 48(6):158-61. PubMed ID: 9813984
[TBL] [Abstract][Full Text] [Related]
5. Imipenem and cephem resistant Pseudomonas aeruginosa carrying plasmids coding for class B beta-lactamase.
Minami S; Akama M; Araki H; Watanabe Y; Narita H; Iyobe S; Mitsuhashi S
J Antimicrob Chemother; 1996 Mar; 37(3):433-44. PubMed ID: 9182100
[TBL] [Abstract][Full Text] [Related]
6. Group 1 beta-lactamases of Aeromonas caviae and their resistance to beta-lactam antibiotics.
Lupiola-Gómez PA; González-Lama Z; Tejedor-Junco MT; González-Martín M; Martín-Barrasa JL
Can J Microbiol; 2003 Mar; 49(3):207-15. PubMed ID: 12795407
[TBL] [Abstract][Full Text] [Related]
7. Biochemical comparison of imipenem, meropenem and biapenem: permeability, binding to penicillin-binding proteins, and stability to hydrolysis by beta-lactamases.
Yang Y; Bhachech N; Bush K
J Antimicrob Chemother; 1995 Jan; 35(1):75-84. PubMed ID: 7768785
[TBL] [Abstract][Full Text] [Related]
8. Distribution and expression of beta-lactamase genes among Aeromonas spp.
Walsh TR; Stunt RA; Nabi JA; MacGowan AP; Bennett PM
J Antimicrob Chemother; 1997 Aug; 40(2):171-8. PubMed ID: 9301981
[TBL] [Abstract][Full Text] [Related]
9. A study of the mechanisms involved in imipenem resistance in Pseudomonas aeruginosa isolates from Japan.
Stunt RA; Thomson CJ; Payne DJ; Amyes SG
J Antimicrob Chemother; 1998 Aug; 42(2):272-3. PubMed ID: 9738853
[No Abstract] [Full Text] [Related]
10. Biochemical characteristics of a carbapenemase from an Acinetobacter baumannii isolate collected in Buenos Aires, Argentina.
Afzal-Shah M; Villar HE; Livermore DM
J Antimicrob Chemother; 1999 Jan; 43(1):127-31. PubMed ID: 10381110
[TBL] [Abstract][Full Text] [Related]
11. Beta-lactam resistance in Aeromonas spp. caused by inducible beta-lactamases active against penicillins, cephalosporins, and carbapenems.
Bakken JS; Sanders CC; Clark RB; Hori M
Antimicrob Agents Chemother; 1988 Sep; 32(9):1314-9. PubMed ID: 3264129
[TBL] [Abstract][Full Text] [Related]
12. Emergence of Serratia marcescens isolates possessing carbapenem-hydrolysing β-lactamase KPC-2 from China.
Lin X; Hu Q; Zhang R; Hu Y; Xu X; Lv H
J Hosp Infect; 2016 Sep; 94(1):65-7. PubMed ID: 27160868
[TBL] [Abstract][Full Text] [Related]
13. Biochemical characterization of the carbapenem-hydrolyzing beta-lactamase AsbM1 from Aeromonas sobria AER 14M: a member of a novel subgroup of metallo-beta-lactamases.
Yang Y; Bush K
FEMS Microbiol Lett; 1996 Apr; 137(2-3):193-200. PubMed ID: 8998985
[TBL] [Abstract][Full Text] [Related]
14. Development of imipenem resistance in an Aeromonas veronii biovar sobria clinical isolate recovered from a patient with cholangitis.
Sánchez-Céspedes J; Figueras MJ; Aspiroz C; Aldea MJ; Toledo M; Alperí A; Marco F; Vila J
J Med Microbiol; 2009 Apr; 58(Pt 4):451-455. PubMed ID: 19273640
[TBL] [Abstract][Full Text] [Related]
15. Meropenem: activity against resistant gram-negative bacteria and interactions with beta-lactamases.
Sanders CC; Sanders WE; Thomson KS; Iaconis JP
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():187-96. PubMed ID: 2808207
[TBL] [Abstract][Full Text] [Related]
16. OXA-162, a novel variant of OXA-48 displays extended hydrolytic activity towards imipenem, meropenem and doripenem.
Kasap M; Torol S; Kolayli F; Dundar D; Vahaboglu H
J Enzyme Inhib Med Chem; 2013 Oct; 28(5):990-6. PubMed ID: 22845331
[TBL] [Abstract][Full Text] [Related]
17. Emergence of imipenem resistance in Klebsiella pneumoniae owing to combination of plasmid-mediated CMY-4 and permeability alteration.
Cao VT; Arlet G; Ericsson BM; Tammelin A; Courvalin P; Lambert T
J Antimicrob Chemother; 2000 Dec; 46(6):895-900. PubMed ID: 11102406
[TBL] [Abstract][Full Text] [Related]
18. Comparative stability of meropenem against beta-lactamases from Bacteroides spp.
Edwards R; Brown J; Greenwood D
Chemotherapy; 1993; 39(6):390-3. PubMed ID: 8222865
[TBL] [Abstract][Full Text] [Related]
19. Comparative in-vitro activity of biapenem against enterobacteria with beta-lactamase-mediated antibiotic resistance.
Chen HY; Livermore DM
J Antimicrob Chemother; 1994 Mar; 33(3):453-64. PubMed ID: 8040111
[TBL] [Abstract][Full Text] [Related]
20. Interactions of biapenem with active-site serine and metallo-beta-lactamases.
Felici A; Perilli M; Segatore B; Franceschini N; Setacci D; Oratore A; Stefani S; Galleni M; Amicosante G
Antimicrob Agents Chemother; 1995 Jun; 39(6):1300-5. PubMed ID: 7574520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
